Effects of COX-2 inhibitor NS-398 on IL-10 expression in rat fungal keratitis

Na Li1, Cheng-Ye Che, Li-Ting Hu

  • 1Department of Ophthalmology, the Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong Province, China.

Abstract

Insights

Interleukin-10 (IL-10) is involved in fungal keratitis. NS-398, a COX-2 inhibitor, increases IL-10 expression in later stages, potentially aiding cornea repair.

Area of Science:

  • Ophthalmology
  • Immunology
  • Pharmacology

Background:

  • Fungal keratitis is a serious eye infection.
  • Interleukin-10 (IL-10) is a key cytokine in immune responses.
  • The role of IL-10 and COX-2 inhibitors in fungal keratitis requires further investigation.

Purpose of the Study:

  • To examine IL-10 expression in a rat model of fungal keratitis.
  • To evaluate the impact of NS-398 (a COX-2 inhibitor) on IL-10 levels.
  • To understand the role of IL-10 in anti-fungal immunity and corneal repair.

Main Methods:

  • Established fungal keratitis in Wistar rats using Fusarium solani.
  • Administered NS-398 eyedrops to one treatment group and PBS to another.
  • Quantified IL-10 expression via immunohistochemistry and RT-PCR at multiple time points.

Main Results:

  • Fungal keratitis induced significant corneal pathology, including neutrophil infiltration and necrosis.
  • IL-10 expression initially rose and then fell in the infected group.
  • NS-398 treatment led to increased IL-10 expression in later stages (7 and 14 days).

Conclusions:

  • IL-10 plays a role in the pathogenesis of fungal keratitis.
  • NS-398 upregulates IL-10 expression during the later phase of fungal keratitis.
  • IL-10 may be crucial for corneal anti-damage repair mechanisms.